Jinyu Bio-Technology Hits Day Low at CNY 12.84 Amid Price Pressure

Jinyu Bio-Technology Co., Ltd. experienced a notable decline today, with its stock price dropping by 3.45% on May 22, 2026. The stock reached an intraday low of CNY 12.84, reflecting ongoing volatility in its performance. Over the past week, Jinyu has seen a significant decrease of 14.27%, contrasting with a slight decline of 0.54% in the China Shanghai Composite index. Despite a strong annual performance of 81.64%, Jinyu's year-to-date results show a decline of 14.66%. The company has faced challenges in profitability, evidenced by a low Return on Capital Employed (ROCE) of 6.64% and a Return on Equity (ROE) of just 0.68%. Additionally, Jinyu has reported negative results for the last four consecutive quarters, with operating cash flow at its lowest point of CNY 303.08 million. The stock's high price-to-book ratio of 3.08 and a P/E ratio of 188.00 indicate a premium valuation, which may not align with its recent financial performance. As Jinyu navigates these trends, its position within the pharmaceuticals and biotechnology sector remains under scrutiny.